Incretins: all 1,182 studies that test it

Page 5 of 12. Open to participants first (46), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)CompletedNCT00877890Phase 3Results posted
• Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)CompletedNCT00875394Phase 3Results posted
• A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus MetforminCompletedNCT00870194Phase 4Results posted
• Sitagliptin Umbilical Cord Blood Transplant StudyCompletedNCT00862719Phase 2Results posted
• The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese SubjectsCompletedNCT00856609Phase 3Results posted
• Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT00856284Phase 3Results posted
• Evaluation of Exenatide in Patients With Diabetic NeuropathyCompletedNCT00855439Not applicableResults posted
• Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension TrialCompletedNCT00851903Phase 3Results posted
• Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese AdultsCompletedNCT00845507Phase 4Results posted
• Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell FunctionCompletedNCT00845182Phase 4Results posted
• Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesTerminatedNCT00837759Phase 2Results posted
• MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)CompletedNCT00837577Phase 3Results posted
• ALPHA Sitagliptin Add on to Metformin (0431-103)CompletedNCT00833027Phase 4Results posted
• The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)TerminatedNCT00832624Phase 4Results posted
• Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)CompletedNCT00832390Phase 4Results posted
• A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)CompletedNCT00830076Phase 1Results posted
• Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DMCompletedNCT00820573Phase 4Results posted
• Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea DrugCompletedNCT00819091Phase 3Results posted
• A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)CompletedNCT00813995Phase 3Results posted
• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background InclusiveCompletedNCT00800683Phase 3Results posted
• Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart FailureTerminatedNCT00799435Phase 4Results posted
• The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill PatientsTerminatedNCT00798590Phase 2Results posted
• Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignCompletedNCT00798161Phase 3Results posted
• Incretin Effect in People With Impaired Fasting GlucoseCompletedNCT00795275Not applicableResults posted
• Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)CompletedNCT00790205Phase 3Results posted
• A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)CompletedNCT00782418Phase 1Results posted
• Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceCompletedNCT00781937Phase 3Results posted
• Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell MassCompletedNCT00775684Not applicableResults posted
• Incretin Effect and Use After Clinical Islet TransplantationCompletedNCT00768651Phase 2Results posted
• Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusCompletedNCT00765817Phase 3Results posted
• Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)CompletedNCT00758069Phase 2Results posted
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without MetforminCompletedNCT00757588Phase 3Results posted
• Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.CompletedNCT00755846Phase 2Results posted
• Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With MetforminCompletedNCT00753896Phase 3Results posted
• BI 10773 add-on to Metformin in Patients With Type 2 DiabetesCompletedNCT00749190Phase 2Results posted
• A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is InappropriateCompletedNCT00740051Phase 3Results posted
• Intravenous Exenatide in Coronary Intensive Care Unit (ICU) PatientsCompletedNCT00736229Phase 4Results posted
• A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)CompletedNCT00730275Phase 1Results posted
• Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a ThiazolidinedioneCompletedNCT00729326Phase 4Results posted
• MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)CompletedNCT00722371Phase 3Results posted
• The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic PatientsCompletedNCT00716092Phase 2Results posted
• Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCompletedNCT00707993Phase 3Results posted
• Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)CompletedNCT00704132Phase 1Results posted
• Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With MetforminTerminatedNCT00701935Phase 2Results posted
• A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)CompletedNCT00701090Phase 3Results posted
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00700817Phase 3Results posted
• Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic ControlCompletedNCT00698932Phase 3Results posted
• A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and LiraglutideCompletedNCT00696657Phase 2Results posted
• The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body CompositionTerminatedNCT00686972Phase 2Results posted
• Sitagliptin in Combination With Metformin and SulfonylureaCompletedNCT00686634Phase 4Results posted
• Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR AloneCompletedNCT00683657Phase 3Results posted
• Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)CompletedNCT00676338Phase 3Results posted
• Effects of Glutamine on GLP-1 and Insulin Secretion in ManCompletedNCT00673894Not applicableResults posted
• How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 DiabeticsCompletedNCT00667732Phase 4Results posted
• 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)CompletedNCT00666458Phase 3Results posted
• Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 DiabetesCompletedNCT00661362Phase 3Results posted
• Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 DiabetesCompletedNCT00660075Phase 3Results posted
• The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic SubjectsCompletedNCT00659711Not applicableResults posted
• Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 DiabetesCompletedNCT00658021Phase 3Results posted
• Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart FailureCompletedNCT00657280Early Phase 1Results posted
• Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.CompletedNCT00655863Phase 3Results posted
• Japanese P III vs Voglibose and PlaceboCompletedNCT00654381Phase 3Results posted
• Role of Exenatide in NASH-a Pilot StudyCompletedNCT00650546Phase 2/3Results posted
• Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)CompletedNCT00641056Phase 3Results posted
• Efficacy vs Placebo as Initial Combination Therapy With PioglitazoneCompletedNCT00641043Phase 3Results posted
• A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)CompletedNCT00637273Phase 3Results posted
• A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)CompletedNCT00631488Phase 2Results posted
• Bioenergetic Alterations After Exenatide AdministrationCompletedNCT00623545Phase 4Results posted
• Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00622284Phase 3Results posted
• Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic ControlCompletedNCT00621140Phase 3Results posted
• The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes MellitusCompletedNCT00620282Phase 3Results posted
• Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal ImpairmentCompletedNCT00614939Phase 3Results posted
• Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00614120Phase 3Results posted
• Effect of GLP-1 on Insulin Biosynthesis and Turnover RatesTerminatedNCT00609154Phase 1/2Results posted
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and MetforminCompletedNCT00603239Phase 3Results posted
• BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 DiabetesCompletedNCT00602472Phase 3Results posted
• Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 DiabetesCompletedNCT00601250Phase 3Results posted
• GLP1R Polymorphisms and Response to GLP1CompletedNCT00588380Not applicableResults posted
• Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)CompletedNCT00577824Phase 3Results posted
• 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension PeriodCompletedNCT00575588Phase 3Results posted
• The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-DiabetesCompletedNCT00546728Phase 4Results posted
• Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)CompletedNCT00541775Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)CompletedNCT00541450Phase 3Results posted
• Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)CompletedNCT00541229Phase 1Results posted
• MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)CompletedNCT00532935Phase 3Results posted
• Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver DiseaseTerminatedNCT00529204Phase 2Results posted
• Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00518882Phase 3Results posted
• A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 DiabetesCompletedNCT00516074Phase 3Results posted
• An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 DiabetesCompletedNCT00516048Phase 3Results posted
• Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)CompletedNCT00511108Phase 1Results posted
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)CompletedNCT00509262Phase 3Results posted
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)CompletedNCT00509236Phase 3Results posted
• A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese PatientsCompletedNCT00500370Phase 2Results posted
• MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)CompletedNCT00482729Phase 3Results posted
• The Effect of Exenatide on Weight and Hunger in Obese, Healthy WomenCompletedNCT00456885Phase 4Results posted
• Role of Exenatide in Type 1 DiabetesCompletedNCT00456300Phase 2Results posted
• Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)CompletedNCT00449930Phase 3Results posted
• Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 DiabetesCompletedNCT00434954Phase 3Results posted
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00432276Phase 3Results posted
• The Effect of Liraglutide on Body Weight in Obese Subjects Without DiabetesCompletedNCT00422058Phase 2Results posted

← Incretins overview